Macrogenics Stock Analysis
MGNX Stock | USD 16.10 0.58 3.48% |
MacroGenics is overvalued with Real Value of 14.25 and Target Price of 12.38. The main objective of MacroGenics stock analysis is to determine its intrinsic value, which is an estimate of what MacroGenics is worth, separate from its market price. There are two main types of MacroGenics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect MacroGenics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of MacroGenics' stock to identify patterns and trends that may indicate its future price movements.
The MacroGenics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. MacroGenics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. MacroGenics Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and MacroGenics' ongoing operational relationships across important fundamental and technical indicators.
MacroGenics |
MacroGenics Stock Analysis Notes
About 100.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.01. MacroGenics recorded a loss per share of 0.15. The entity had not issued any dividends in recent years. MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. The company was incorporated in 2000 and is headquartered in Rockville, Maryland. Macrogenics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 427 people. To find out more about MacroGenics contact Scott MD at 301 251 5172 or learn more at https://www.macrogenics.com.MacroGenics Quarterly Total Revenue |
|
MacroGenics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. MacroGenics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding MacroGenics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
MacroGenics is way too risky over 90 days horizon | |
MacroGenics appears to be risky and price may revert if volatility continues | |
The company reported the previous year's revenue of 58.75 M. Net Loss for the year was (9.06 M) with loss before overhead, payroll, taxes, and interest of (62.47 M). | |
MacroGenics currently holds about 133.74 M in cash with (78.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.18. | |
MacroGenics has a poor financial position based on the latest SEC disclosures | |
Over 100.0% of the company shares are owned by institutional investors | |
Latest headline from investing.com: MacroGenics senior VP sells over 799k in company stock |
MacroGenics Upcoming and Recent Events
Earnings reports are used by MacroGenics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to MacroGenics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
20th of March 2024 Upcoming Quarterly Report | View | |
14th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
20th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
MacroGenics Largest EPS Surprises
Earnings surprises can significantly impact MacroGenics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2014-05-06 | 2014-03-31 | -0.08 | -0.12 | -0.04 | 50 | ||
2023-03-15 | 2022-12-31 | 0.1 | 0.21 | 0.11 | 110 | ||
2020-05-05 | 2020-03-31 | -1.02 | -0.91 | 0.11 | 10 |
MacroGenics Thematic Classifications
In addition to having MacroGenics stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Cancer FightersPublic companies from health care and pharmaceutical sectors that are focused on fighting cancer |
MacroGenics Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as MacroGenics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MacroGenics backward and forwards among themselves. MacroGenics' institutional investor refers to the entity that pools money to purchase MacroGenics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Dimensional Fund Advisors, Inc. | 2023-12-31 | 1.2 M | Rock Springs Capital Management Lp | 2023-12-31 | 1.2 M | Jpmorgan Chase & Co | 2023-12-31 | 1.1 M | Acadian Asset Management Llc | 2023-12-31 | 1.1 M | Millennium Management Llc | 2023-12-31 | 863 K | Charles Schwab Investment Management Inc | 2023-12-31 | 833.5 K | Federated Hermes Inc | 2023-12-31 | 803.4 K | Northern Trust Corp | 2023-12-31 | 774.5 K | Renaissance Technologies Corp | 2023-12-31 | 763.5 K | Bellevue Group Ag | 2023-12-31 | 10 M | Blackrock Inc | 2023-12-31 | 6.1 M |
MacroGenics Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.01 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MacroGenics's market, we take the total number of its shares issued and multiply it by MacroGenics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.MacroGenics Profitablity
MacroGenics' profitability indicators refer to fundamental financial ratios that showcase MacroGenics' ability to generate income relative to its revenue or operating costs. If, let's say, MacroGenics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, MacroGenics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of MacroGenics' profitability requires more research than a typical breakdown of MacroGenics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.15) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (4.6) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $4.6. Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.03) | (0.03) | |
Return On Capital Employed | (0.69) | (0.66) | |
Return On Assets | (0.03) | (0.03) | |
Return On Equity | (0.06) | (0.06) |
Management Efficiency
MacroGenics has return on total asset (ROA) of (0.3633) % which means that it has lost $0.3633 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0615) %, meaning that it created substantial loss on money invested by shareholders. MacroGenics' management efficiency ratios could be used to measure how well MacroGenics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.03 in 2024. Return On Capital Employed is likely to rise to -0.66 in 2024. Net Tangible Assets is likely to rise to about 245.6 M in 2024, whereas Total Assets are likely to drop slightly above 287.5 M in 2024.Last Reported | Projected for Next Year | ||
Book Value Per Share | 0 | 0 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | 0 | 0 | |
Enterprise Value Over EBITDA | -3.5 K | -3.4 K | |
Price Book Value Ratio | 3.9 K | 4.1 K | |
Enterprise Value Multiple | -3.5 K | -3.4 K | |
Price Fair Value | 3.9 K | 4.1 K | |
Enterprise Value | 304.3 M | 442.4 M |
The analysis of MacroGenics' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze MacroGenics' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of MacroGenics Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 2.106 |
Technical Drivers
As of the 19th of April, MacroGenics secures the Mean Deviation of 3.65, downside deviation of 4.3, and Risk Adjusted Performance of 0.0932. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MacroGenics, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for MacroGenics, which can be compared to its peers in the industry. Please verify MacroGenics mean deviation, information ratio, as well as the relationship between the Information Ratio and downside variance to decide if MacroGenics is priced some-what accurately, providing market reflects its recent price of 16.1 per share. Given that MacroGenics has jensen alpha of 0.6784, we recommend you to check MacroGenics's last-minute market performance to make sure the company can sustain itself at a future point.MacroGenics Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. MacroGenics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for MacroGenics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
MacroGenics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific MacroGenics insiders, such as employees or executives, is commonly permitted as long as it does not rely on MacroGenics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases MacroGenics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jeffrey Peters over three weeks ago Acquisition by Jeffrey Peters of 54376 shares of MacroGenics at 11.5 subject to Rule 16b-3 | ||
Jeffrey Peters over a month ago Disposition of 10875 shares by Jeffrey Peters of MacroGenics at 11.5 subject to Rule 16b-3 | ||
David Stump over six months ago Acquisition by David Stump of 19000 shares of MacroGenics subject to Rule 16b-3 |
MacroGenics Predictive Daily Indicators
MacroGenics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of MacroGenics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
MacroGenics Corporate Filings
8th of April 2024 Other Reports | ViewVerify | |
8K | 3rd of April 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 8th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 7th of March 2024 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
F4 | 6th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 28th of February 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 26th of February 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 20th of February 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
MacroGenics Forecast Models
MacroGenics' time-series forecasting models are one of many MacroGenics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MacroGenics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About MacroGenics Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how MacroGenics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MacroGenics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as MacroGenics. By using and applying MacroGenics Stock analysis, traders can create a robust methodology for identifying MacroGenics entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.15) | (0.16) | |
Operating Profit Margin | (2.86) | (2.72) | |
Net Loss | (0.15) | (0.16) | |
Gross Profit Margin | 0.99 | 1.04 |
Current MacroGenics Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. MacroGenics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. MacroGenics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
12.38 | Strong Buy | 11 | Odds |
Most MacroGenics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand MacroGenics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of MacroGenics, talking to its executives and customers, or listening to MacroGenics conference calls.
MacroGenics Stock Analysis Indicators
MacroGenics stock analysis indicators help investors evaluate how MacroGenics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading MacroGenics shares will generate the highest return on investment. By understating and applying MacroGenics stock analysis, traders can identify MacroGenics position entry and exit signals to maximize returns.
Begin Period Cash Flow | 108.9 M | |
Common Stock Shares Outstanding | 61.9 M | |
Total Stockholder Equity | 152.6 M | |
Property Plant And Equipment Net | 45.7 M | |
Cash And Short Term Investments | 229.8 M | |
Cash | 101 M | |
Accounts Payable | 6.4 M | |
Net Debt | -67 M | |
50 Day M A | 17.0004 | |
Total Current Liabilities | 56.1 M | |
Other Operating Expenses | 227 M | |
Non Current Assets Total | 47.1 M | |
Non Currrent Assets Other | 1.4 M | |
Stock Based Compensation | 18.4 M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MacroGenics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for MacroGenics Stock analysis
When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Stocks Directory Find actively traded stocks across global markets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is MacroGenics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MacroGenics. If investors know MacroGenics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MacroGenics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 0.949 | Quarterly Revenue Growth (0.85) | Return On Assets (0.36) | Return On Equity (0.06) |
The market value of MacroGenics is measured differently than its book value, which is the value of MacroGenics that is recorded on the company's balance sheet. Investors also form their own opinion of MacroGenics' value that differs from its market value or its book value, called intrinsic value, which is MacroGenics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MacroGenics' market value can be influenced by many factors that don't directly affect MacroGenics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MacroGenics' value and its price as these two are different measures arrived at by different means. Investors typically determine if MacroGenics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MacroGenics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.